Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
QuintilesIMS
US Department of Justice
Farmers Insurance
Citi
Medtronic

Generated: August 19, 2019

DrugPatentWatch Database Preview

Claims for Patent: 8,450,337

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,450,337
Title:Methods of treating skin disorders with caffeic acid analogs
Abstract: Embodiments of the invention generally relate to pharmaceutical compositions containing at least one caffeic acid compound and methods for the topical treatment of proliferative and inflammatory skin disorders such as plaque psoriasis, atopic dermatitis, and other disorders. In some embodiments, the topical treatment includes applications of the pharmaceutical composition containing at least one caffeic acid compound or a mixture of caffeic acid compounds such as caffeic acid ester compounds, caffeic acid amide compounds, analogues thereof, derivatives thereof, salts thereof, or mixtures thereof. The pharmaceutical composition or topical dosage may contain the caffeic acid compound at a concentration by weight within a range from about 0.01% to about 20%, preferably, from about 0.1% to about 15%, preferably, from about 1% to about 10%, more preferably, from about 3% to about 7%, and more preferably, from about 4% to about 6%.
Inventor(s): Priebe; Waldemar (Houston, TX), Conrad; Charles (Spring, TX), Madden; Timothy (Sugar Land, TX)
Assignee: Moleculin, LLC (Houston, TX)
Application Number:12/570,819
Patent Claims:1. A pharmaceutical composition for topical application to psoriatic lesions, comprising: a carrier suitable for topical administration; and a caffeic acid amide compound having the chemical structure: ##STR00052## wherein the caffeic acid amide compound is present at a concentration by weight within a range from about 0.01% to about 20% of the pharmaceutical composition.

2. The pharmaceutical composition of claim 1, wherein the topical pharmaceutical composition comprises the caffeic acid amide compound at a concentration by weight within a range from about 1% to about 10%.

3. The pharmaceutical composition of claim 2, wherein the topical pharmaceutical composition comprises the caffeic acid amide compound at a concentration by weight within a range from about 3% to about 7%.

4. The pharmaceutical composition of claim 1, further comprising petroleum jelly or dimethyl sulfoxide.

5. The pharmaceutical composition of claim 1, further comprising at least one compound selected from the group consisting of cell differentiating agents, anti-proliferative agents, mitochondrial inhibitors, topical steroids, immunosuppressive compounds, JAK2 inhibitors, JAK3 inhibitors, parathyroid hormone-related protein (PTHrP) agonists, cell adhesion blockers, and combinations thereof.

6. The pharmaceutical composition of claim 1, further comprising a cell differentiating agent selected from at least one of retinoic acid, retinoic acid derivative, vitamin D, or vitamin D analog.

Details for Patent 8,450,337

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Try a Free Trial Moleculin, LLC (Houston, TX) 2036-04-30 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Try a Free Trial Moleculin, LLC (Houston, TX) 2036-04-30 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Try a Free Trial Moleculin, LLC (Houston, TX) 2036-04-30 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Try a Free Trial Moleculin, LLC (Houston, TX) 2036-04-30 RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cipla
UBS
Merck
US Army
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.